tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mirum Pharmaceuticals price target raised to $80 from $73 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Mirum Pharmaceuticals (MIRM) to $80 from $73 and keeps a Buy rating on the shares post the Q2 report. The firm says Livmarli commercial momentum drove up the company’s 2025 revenue guidance.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1